ExThera Medical Overview
- Founded
-
2007

- Status
-
Private
- Employees
-
27

- Latest Deal Type
-
Series B3
- Latest Deal Amount
-
$6.71M
- Investors
-
5
ExThera Medical General Information
Description
Developer of extracorporeal blood filtration devices designed to offer treatment of bloodstream infections. The company's medical devices include a single-use blood filter capable of capturing and removing a broad range of bacteria, viruses, parasites, toxins and other harmful substances from whole blood, enabling clinics and healthcare organizations to address unmet clinical needs of pathogen reduction in blood banking.
Contact Information
Website
www.extheramedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
- 757 Arnold Drive
- Suite B
- Martinez, CA 94553
- United States
+1 (925) 000-0000
ExThera Medical Timeline
ExThera Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series B3) | 10-Sep-2021 | $6.71M | 000.00 | 000.00 | Completed | Generating Revenue |
4. Later Stage VC (Series B1) | 17-Mar-2021 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC (Series B) | 11-May-2016 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Later Stage VC (Series A) | 11-May-2016 | $12M | $12M | 000.00 | Completed | Generating Revenue |
1. Joint Venture | 01-Jan-2007 | Completed | Startup |
ExThera Medical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B-3 | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Series B-2 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B-1 | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Series B | 9,491,945 | $0.001000 | $0.15 | $1.82 | $1.82 | 1x | $1.82 | 13.74% |
Series A | 12,008,982 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 17.38% |
ExThera Medical Patents
ExThera Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3137294-A1 | Method for modulating endothelial glycocalyx structure | Pending | 16-May-2019 | 0000000000 | |
US-10786615-B2 | Method for treating drug intoxication | Active | 02-Mar-2016 | 0000000000 | 00 |
US-20170252502-A1 | Method for treating drug intoxication | Granted | 02-Mar-2016 | 0000000000 | |
US-20210008269-A1 | Method for treating drug intoxication | Pending | 02-Mar-2016 | 000000000 | |
EP-3422943-A4 | Method for treating drug intoxication | Pending | 02-Mar-2016 | A61M1/3621 |
ExThera Medical Executive Team (7)
ExThera Medical Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Eber Jaques | Self | Board Member | 000 0000 |
Erin Borger | ExThera Medical | Board Member | 000 0000 |
Gregory Dollarhyde | Self | Board Member | 000 0000 |
John Feik | Self | Board Member | 000 0000 |
John Preston | Self | Board Member | 000 0000 |
ExThera Medical Signals
ExThera Medical Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Cycad Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
NaHCO3 | Impact Investing | Minority | 000 0000 | 000000 0 | |
Fresenius Medical Care Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Emergence Venture Partners | Venture Capital | Majority | 000 0000 | 000000 0 | |
ExThera AB | Corporation | Majority | 000 0000 | 000000 0 |